logo

Biotech Stocks Facing FDA Decision In March

Biotech Stocks Facing FDA Decision In March
Biotech Stocks Facing FDA Decision In March

After a banner year in 2018, the novel drug approval is off to an uncharacteristically slow start this year. No novel drug was approved in January and three were approved in February.

Now, let's take a look at the companies that await a ruling from the FDA in March 2019.

Share